Drug intelligence / Profile preview

carboxymethylcellulose sodium + glycerin (Grevis Pharmaceuticals)

Development stage: Unknown
Lead developer: Grevis Pharma
Modality: Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration: Ophthalmic

Overview

Cellu Tears Ultra is an ophthalmic lubricant formulation developed by Grevis Pharma. It is a fixed-dose combination of carboxymethylcellulose sodium and glycerin, designed to provide temporary relief from burning, irritation, and discomfort caused by dry eyes. Carboxymethylcellulose sodium acts as a mucoadhesive lubricant that increases tear viscosity and stabilizes the tear film, while glycerin serves as an ophthalmic demulcent that lubricates the mucous membrane surface of the eye. Together, these active ingredients help restore natural moisture and protect the ocular surface from further irritation or damage.

Brand names: Cellu Tears Ultra
Other names: Cellu Tears Ultra Eye Ointment

Beyond the preview

Go deeper on carboxymethylcellulose sodium + glycerin (Grevis Pharmaceuticals).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on carboxymethylcellulose sodium + glycerin (Grevis Pharmaceuticals).